查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1705972

全球霍亂疫苗市場按產品類型、疫苗類型、患者類型、分銷管道和地區分類

Global Cholera Vaccines Market, By Product Type, By Vaccine Type, By Patient Type, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球霍亂疫苗市場規模估計為 8,270 萬美元，預計到 2032 年將達到 1.851 億美元，2025 年至 2032 年的年複合成長率(CAGR)為 12.20%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 8270萬美元
效能數據 2020-2024 預測期 2025-2032
預測期：2025-2032年複合年成長率： 12.20% 2032年價值預測 1.851億美元
數字。 2025年全球市場佔有率（按地區）
全球霍亂疫苗市場-IMG1

霍亂是一種細菌性疾病，通常透過受污染的水傳播。它會導致嚴重的腹瀉和脫水，如果不及時治療，可能會在幾個小時內致命。這種疾病在水處理不良、衛生條件差和不衛生的地區最為常見，包括非洲、東南亞和海地。世界衛生組織（WHO）和聯合國兒童基金會（UNICEF）警告稱，霍亂正在以毀滅性的方式死灰復燃，尤其針對脆弱群體。在貧窮、戰爭或天災迫使人們生活在擁擠且缺乏足夠衛生設施的地方，霍亂爆發的風險最大。霍亂是一種貧困疾病，影響那些無法獲得安全飲用水和基本衛生設施的人。霍亂不會在人與人之間直接傳播，因此與感染者的偶然接觸並不是罹患此疾病的重要風險因子。多管齊下的預防方法是消除霍亂和減少死亡的關鍵。這包括在高風險地區獲得安全飲用水、適當的衛生設施和衛生習慣以及疫苗接種。

市場動態：

推動全球霍亂疫苗市場成長的關鍵因素包括全球霍亂疾病負擔的增加、對預防霍亂疫情的日益關注以及市場上出現可提供更長保護時間的新型口服疫苗。然而，低收入地區疫苗接種可近性不足、部分地區疫苗接種意識低下等因素持續在一定程度上限制市場潛力。樂觀的一面是，加大對可對多種血清型提供交叉保護的疫苗的研究投入，正在開闢新的途徑。製造商和國際組織之間為提高流行地區的供應而夥伴關係也為未來幾年帶來了誘人的機會。

本研究的主要特點

  • 本報告對全球霍亂疫苗市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率(CAGR)。
  • 它還強調了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 該報告涵蓋了全球霍亂疫苗市場的主要企業概況，基於公司亮點、產品系列、主要產品亮點、財務表現和策略等參數。
  • 從本報告中獲得的見解將使負責人和企業經營團隊能夠就未來的產品發布、高階市場策略、市場擴張和行銷策略做出明智的決策。
  • 全球霍亂疫苗市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 透過用於分析全球霍亂疫苗市場的各種策略矩陣，相關人員可以更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 加強疫苗宣傳活動
    • 霍亂疫苗供不應求
    • 增加教育和培訓項目
  • 主要亮點
  • 監管情景
  • 市場趨勢
  • 管道分析
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 流行病學
  • 治療流程（病人歷程）
  • 治療方案分析
  • 主要市場參與者的新投資
  • 定價分析
  • 疾病意識計劃
  • 分析治療的安全性和有效性
  • 合併、收購和合作

4. 全球霍亂疫苗市場-冠狀病毒（COVID-19）大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球霍亂疫苗市場（依產品類型）

  • 瓦什科拉
  • 杜科拉爾
  • ShanChol
  • Euvichol-Plus/ Euvichol
  • 其他（後期疫苗等）

6. 2020-2032 年全球霍亂疫苗市場（依疫苗類型）

  • 去活化全細胞和重組霍亂毒素B疫苗
  • 去活化全細胞疫苗
  • 口服霍亂減毒活疫苗

7. 2020-2032 年全球霍亂疫苗市場（依病患類型）

  • 孩子們
  • 成人

8. 2020-2032 年全球霍亂疫苗市場（依通路分類）

  • 公共
  • 私人的

9. 2020-2032 年全球霍亂疫苗市場（按地區）

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第10章 競爭格局

  • 公司簡介
    • Sanofi
    • Biovac.co.za.
    • EMERGENT
    • Celldex Therapeutics
    • Valneva SE
    • Hilleman Laboratories
    • Shanghai United Cell Biotechnology Co., Ltd（Hillhouse Capital）
    • PaxVax, Inc.
    • Astellas Pharma Inc.
    • EUBIOLOGICS CO., LTD.

第 11 章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6646

Global Cholera Vaccines Market is estimated to be valued at USD 82.7 Mn in 2025 and is expected to reach USD 185.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.20% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 82.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.20% 2032 Value Projection: USD 185.1 Mn
Figure. Global Cholera Vaccines Market Share (%), By Region 2025
Global Cholera Vaccines Market - IMG1

Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inadequate hygiene, such as Africa, Southeast Asia, and Haiti. The World Health Organization (WHO) and the UN Children's Fund (UNICEF) have warned that cholera is making a devastating comeback, particularly targeting vulnerable communities. The risk of a cholera epidemic is highest when poverty, war, or natural disasters force people to live in crowded conditions without adequate sanitation. Cholera is a disease of poverty, affecting people with inadequate access to safe water and basic sanitation. The infection is not likely to spread directly from one person to another; therefore, casual contact with an infected person is not a significant risk factor for becoming ill. In terms of prevention, a multifaceted approach is key to controlling cholera and reducing deaths. This includes ensuring access to safe water, adequate sanitation, and hygiene, as well as vaccination in high-risk areas.

Market Dynamics:

Key drivers favoring the growth of global cholera vaccines market include the rising burden of cholera disease globally, growing focus on preventing cholera outbreaks, and the development of novel oral vaccines with a longer duration of protection. However, factors such as insufficient access to vaccines in low-income regions, and a lack of awareness about immunization in certain communities continue to restrain the market potential to a certain extent. On the optimistic side, increasing investments in the research of vaccines providing cross-protection against multiple serotypes open up new avenues. Partnerships between makers and international organizations for improving availability in endemic areas also present attractive opportunities over the next few years.

Key features of the study:

  • This report provides in-depth analysis of the global cholera vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cholera vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include Sanofi, Biovac.co.za., EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital), PaxVax, Inc., Astellas Pharma Inc., and EUBIOLOGICS CO., LTD.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cholera vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cholera vaccines market

Detailed Segmentation:

  • Global Cholera Vaccines Market, By Product Type
    • Vaxchora
    • Dukoral
    • ShanChol
    • Euvichol-Plus/Euvichol
    • Others (Late Phase Vaccines, etc.)
  • Global Cholera Vaccines Market, By Vaccine Type
    • Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
    • Killed Whole-cell Only Vaccines
    • Live Attenuated Oral Cholera Vaccine
  • Global Cholera Vaccines Market, By Patient Type
    • Pediatric
    • Adults
  • Global Cholera Vaccines Market, By Distribution Channel
    • Public
    • Private
  • Global Cholera Vaccines Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • Sanofi
    • Biovac.co.za.
    • EMERGENT
    • Celldex Therapeutics
    • Valneva SE
    • Hilleman Laboratories
    • Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
    • PaxVax, Inc.
    • Astellas Pharma Inc.
    • EUBIOLOGICS CO., LTD.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Vaccine Type
    • Market Snippet, By Patient Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing Vaccination Campaigns
    • Supply Shortage of Cholera Vaccine
    • Increasing Educational Training Programmes
  • Key Highlights
  • Regulatory Scenario
  • Market Trends
  • Pipeline Analysis
  • Product Launch/Approval
  • PEST Analysis
  • PORTER's Analysis
  • Epidemiology
  • Treatment Algorithm (Patient Journey)
  • Treatment Option Analysis
  • New Investments by Major Market Players
  • Pricing Analysis
  • Disease Awareness Programs
  • Treatment Safety and Efficacy Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Cholera Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cholera Vaccines Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Vaxchora
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Dukoral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • ShanChol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Euvichol-Plus/Euvichol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Late Phase Vaccines, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Cholera Vaccines Market, By Vaccine Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Killed Whole-cell Only Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Live Attenuated Oral Cholera Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Cholera Vaccines Market, By Patient Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Cholera Vaccines Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 201s9-2032,(US$ Mn)

9. Global Cholera Vaccines Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profile
    • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Biovac.co.za.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • EMERGENT
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Celldex Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Valneva SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Hilleman Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • PaxVax, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Astellas Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • EUBIOLOGICS CO., LTD.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us